|
Constantinou, A I; Kamath, N; Murley, J S (1998) Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur J Cancer 34:1927-34
|
|
Constantinou, A I; Krygier, A E; Mehta, R R (1998) Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice. Am J Clin Nutr 68:1426S-1430S
|
|
Murley, J S; Constantinou, A; Kamath, N S et al. (1997) WR-1065, an active metabolite of the cytoprotector amifostine, affects phosphorylation of topoisomerase II alpha leading to changes in enzyme activity and cell cycle progression in CHO AA8 cells. Cell Prolif 30:283-94
|
|
Moon, R C; Constantinou, A I (1997) Dietary retinoids and carotenoids in rodent models of mammary tumorigenesis. Breast Cancer Res Treat 46:181-9
|
|
Constantinou, A; Mehta, R; Runyan, C et al. (1995) Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships. J Nat Prod 58:217-25
|
|
Constantinou, A; Huberman, E (1995) Genistein as an inducer of tumor cell differentiation: possible mechanisms of action. Proc Soc Exp Biol Med 208:109-15
|
|
Constantinou, A; Stoner, G D; Mehta, R et al. (1995) The dietary anticancer agent ellagic acid is a potent inhibitor of DNA topoisomerases in vitro. Nutr Cancer 23:121-30
|
